OGI

+ Watchlist + Portfolio

Organigram Global Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $1.24
52-Week Range: $0.85 – $2.24
Market Cap: $169.21M
P/E (TTM): 2.79
EPS (TTM): 0.43
Dividend Yield: —

Advanced Metrics

Price/Book: 0.46
PEG Ratio: —
Return on Equity: 17.56%
Return on Assets: -0.60%
Gross Margin: 36.54%
Operating Margin: 5.04%
Profit Margin: 28.02%
Current Ratio: 2.61
Debt/Equity: 0.04
Total Debt: $20.97M
Free Cash Flow: $421.50K
Revenue Growth: 49.40%
Earnings Growth: —
Enterprise Value: $247.93M

OGI Income statement, annual periods, in CAD
CAD	FY2021	FY2022	FY2024	FY2025
Revenue	$79.16M	$145.81M	$159.84M	$259.18M
Cost of Revenue	$107.56M	$114.24M	$112.32M	$168.97M
Gross Profit	-$28.40M	$31.57M	$47.52M	$90.22M
Research & Development	$3.65M	$5.96M	$11.20M	$10.95M
Selling, General & Admin	$46.47M	$59.21M	$67.23M	$86.88M
Operating Expenses	$44.44M	$70.32M	$82.28M	$105.52M
Operating Income	-$72.84M	-$38.75M	-$34.76M	-$15.30M
EBITDA	-$96.71M	$10.96M	-$22.68M	$2.67M
Pretax Income	-$130.70M	-$14.37M	-$45.44M	-$38.53M
Income Tax	$0.00	-$88.00K	$0.00	-$13.77M
Net Income	-$130.70M	-$14.28M	-$45.44M	-$24.76M
Diluted EPS	-2.04	-0.18	-0.48	-0.19
Diluted Shares	64.03M	77.23M	95.29M	127.67M

OGI Balance Sheet statement, annual periods, in CAD
CAD	FY2021	FY2022	FY2024	FY2025
Cash & Equivalents	$55.37M	$68.52M	$106.75M	$28.20M
Receivables	$21.29M	$46.37M	$37.15M	$64.86M
Inventory	$48.82M	$68.28M	$82.52M	$123.95M
Current Assets	$260.62M	$221.62M	$262.22M	$284.90M
Total Assets	$554.02M	$577.11M	$407.86M	$562.21M
Current Liabilities	$26.27M	$55.28M	$53.32M	$126.16M
Long-Term Debt	$230.00K	$155.00K	$25.00K	—
Total Debt	$5.95M	$3.36M	$4.46M	$8.75M
Total Liabilities	$74.21M	$69.05M	$101.87M	$213.08M
Retained Earnings	-$275.64M	-$289.93M	-$583.97M	-$608.73M
Shareholders' Equity	$479.81M	$508.06M	$305.99M	$349.13M
Working Capital	$234.35M	$166.34M	$208.90M	$158.74M

OGI Cash Flow statement, annual periods, in CAD
CAD	FY2021	FY2022	FY2024	FY2025
Operating Cash Flow	-$28.59M	-$36.21M	$3.87M	-$7.59M
Capital Expenditure	-$12.29M	-$48.78M	-$5.34M	-$17.05M
Free Cash Flow	-$40.88M	-$84.99M	-$1.47M	-$24.64M
Depreciation & Amortisation	$31.03M	$24.91M	$12.08M	$17.98M
Stock-Based Compensation	$3.90M	$5.13M	$7.18M	$4.22M
Investing Cash Flow	-$115.11M	$44.03M	-$30.80M	-$81.07M
Financing Cash Flow	$174.46M	$5.33M	$107.78M	$39.33M
Dividends Paid	$0.00	$0.00	—	—
Net Change in Cash	$30.77M	$13.15M	$80.85M	-$49.32M

OGI Income statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$65.60M	$70.79M	$80.06M	$63.54M	$59.79M
Cost of Revenue	$47.18M	$44.65M	$48.22M	$40.22M	$43.39M
Gross Profit	$18.42M	$26.15M	$31.84M	$23.32M	$16.41M
Research & Development	$2.66M	$2.76M	$3.15M	$2.08M	$2.02M
Selling, General & Admin	$21.14M	$23.24M	$25.31M	$22.43M	$22.01M
Operating Expenses	$26.00M	$28.25M	$30.65M	$26.73M	$26.20M
Operating Income	-$7.58M	-$2.10M	$1.19M	-$3.42M	-$9.79M
EBITDA	-$2.74M	$2.68M	$6.15M	$1.56M	-$4.76M
Pretax Income	$42.35M	-$16.20M	-$41.73M	$19.97M	-$921.00K
Income Tax	-$106.00K	-$9.90M	-$3.76M	—	$0.00
Net Income	$42.46M	-$6.29M	-$37.96M	$19.97M	-$921.00K
Diluted EPS	0.32	-0.05	—	0.15	-0.01
Diluted Shares	133.51M	133.91M	—	136.77M	131.57M

OGI Balance Sheet statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$13.18M	$35.88M	$28.20M	$7.58M	$4.29M
Receivables	$49.99M	$57.55M	$64.86M	$49.94M	$53.39M
Inventory	$115.05M	$125.19M	$123.95M	$132.71M	$135.16M
Current Assets	$258.50M	$277.78M	$284.90M	$256.55M	$250.09M
Total Assets	$537.90M	$564.62M	$562.21M	$530.67M	$521.31M
Current Liabilities	$75.62M	$107.28M	$126.16M	$94.05M	$88.75M
Total Debt	$9.54M	$9.15M	$8.75M	$8.45M	$8.20M
Total Liabilities	$147.34M	$179.12M	$213.08M	$161.22M	$149.50M
Retained Earnings	-$564.47M	-$570.76M	-$608.73M	-$588.76M	-$589.68M
Shareholders' Equity	$390.57M	$385.50M	$349.13M	$369.46M	$371.81M
Working Capital	$182.88M	$170.51M	$158.74M	$162.49M	$161.34M

OGI Cash Flow statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$16.59M	$14.63M	-$1.45M	-$16.01M	-$6.76M
Capital Expenditure	-$6.55M	-$9.63M	—	-$2.10M	-$246.00K
Free Cash Flow	-$23.14M	$5.00M	-$688.00K	-$18.12M	-$7.01M
Depreciation & Amortisation	$4.84M	$4.79M	$4.96M	$4.98M	$5.03M
Stock-Based Compensation	$938.00K	$1.01M	$947.00K	$770.00K	$728.00K
Investing Cash Flow	-$10.30M	-$9.43M	$214.00K	-$4.34M	-$1.41M
Financing Cash Flow	$40.66M	-$560.00K	-$565.00K	-$450.00K	-$451.00K
Net Change in Cash	$13.78M	$4.64M	-$1.80M	-$20.81M	-$8.62M

Market Snapshot

About

Canadian cannabis producer cultivating and distributing medical and recreational cannabis products. The company operates indoor growing facilities and produces a range of dried flower, oils, edibles, and vape products under multiple brands for the domestic and international markets.